Purchase Order 36C24226P0109
- Not listed
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the supply of TARPEYO (budesonide) 4mg prescription medication to the VA's Veterans Integrated Service Network (VISN) 2, which serves the New York Harbor region. The total ceiling value of the contract is $10,897.20, with a period of performance through May 2, 2025. The contract...
- This federal contract award, valued at $10,897.20, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO (budesonide) 4mg prescription medication to the New York Harbor. The contract is a firm fixed-price purchase order with a completion date of May 28, 2025. This contract does not have a...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency provision of TARPEYO 4mg prescription medication, with a ceiling value of $10,896.98 and a performance period ending on November 2, 2025. The contract was awarded on October 2, 2025, and does not have a set-aside...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,896.98 firm fixed-price purchase order contract to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the provision of TARPEYO 4MG NDC 81749-0004-01, an emergency medication. The contract has an ultimate completion date of August 22, 2025 and was awarded on August 15, 2025. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialized pharmacy that focuses on...
- This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
- This is a federal contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the purchase of TARPEYO 4MG for the New York Harbor, with an ultimate completion date of November 5, 2025 and a ceiling value of $10,896.98. The contract is a firm fixed-price purchase order and does not have a set-aside designation. Pantherx Specialty, LLC is the...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the supply of TARPEYO 4MG, a prescription medication, to the New York Harbor VA Medical Center. The contract has a ceiling value of $10,896.98 and an ultimate completion date of June 23, 2025. The contract does...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network (VISN) 2 to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the provision of TARPEYO 4MG for the New York Harbor, Margaret Cochran Corbin VAMC, with a ceiling value of $10,896.98 and a period of performance through November 2, 2025. The contract was awarded on October 3, 2025, and does not have a set-aside designation....
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] for the Boro VAMC Pharmacy. The contract, valued at $6,048.81, was issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a completion date of April 2024. This delivery order was not set aside for any specific socioeconomic category. Ardelyx currently holds...
- The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company, for the provision of TARPEYO, a specialized medication used to treat primary immunoglobulin A nephropathy, a serious renal condition affecting veterans. This $261,527.52 firm fixed-price contract, which does not have a set-aside designation, is a delivery order against Calliditas Therapeutics' existing Federal Supply Schedule (FSS)...
Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, was awarded a firm fixed-price purchase order valued at $10,896.98 by Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs. The award, dated October 30, 2025, covers the supply of Tarpeyo 4mg (budesonide), a specialty pharmaceutical product, with performance occurring in Pittsburgh, Pennsylvania and ultimate completion targeted for November 30, 2025. No set-aside designation was utilized for this contract. Pantherx Specialty, a Pittsburgh-based subsidiary of Centene Corporation, serves as the prime contractor and has established itself as a targeted provider of specialized pharmaceutical solutions to federal healthcare agencies, particularly the VA and Department of Justice Bureau of Prisons. This purchase order reflects the routine procurement pattern by VISN 2 for specialized medications supporting the healthcare needs of veterans. Tarpeyo is indicated for the treatment of immunoglobulin A nephropathy, a rare kidney disease, and represents the type of specialized pharmaceutical product that aligns with Pantherx Specialty's core business focus. The contract structure and modest ceiling value are consistent with the vendor's historical federal award profile, which typically consists of firm fixed-price purchase orders for rare disease medications ranging between $10,000 and $43,869, with short contract periods to support emergency and specialized prescription requirements for the veteran population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 10/30/25 |